Splenectomy; Status Clinical Trials

7 recruiting

Splenectomy; Status Trials at a Glance

7 actively recruiting trials for splenectomy; status are listed on ClinicalTrialsFinder across 4 cities in 3 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Yangzhou, Rome, and Roma. Lead sponsors running splenectomy; status studies include Northern Jiangsu People's Hospital, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Medical University of Vienna.

Browse splenectomy; status trials by phase

Treatments under study

About Splenectomy; Status Clinical Trials

Looking for clinical trials for Splenectomy; Status? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Splenectomy; Status trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Splenectomy; Status clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method

AspleniaSplenectomy; StatusSplenectomized Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT07428005
Recruiting

Evaluation of the Effectiveness of an Educational Intervention in Splenectomized Patients

AspleniaSplenectomy; StatusSplenectomy+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled2 locationsNCT07354893
Recruiting
Not Applicable

Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients

Cirrhoses, LiverSplenectomy; StatusPartial
Northern Jiangsu People's Hospital30 enrolled1 locationNCT07205471
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Cirrhosis, LiverSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05338294
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients

Cirrhosis, LiverSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05325424
Recruiting
Not Applicable

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Cirrhosis, LiverPortal HypertensionSplenectomy; Status
Northern Jiangsu People's Hospital20 enrolled1 locationNCT05325437
Recruiting
Phase 2

Meningococcal B Vaccine in Patients with Asplenia

Splenectomy; Status
Medical University of Vienna80 enrolled1 locationNCT06025487